Puma Biotech (PBYI) Reports Q4 Loss of $1.23/Share
Tweet
Share
E-mailGet Alerts PBYI Hot Sheet
Join SI Premium – FREE
Puma Biotech (NYSE: PBYI) reported Q4 EPS of ($1.23), versus ($1.03) reported last year.
For earnings history and earnings-related data on Puma Biotech (PBYI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- JPMorgan Downgrades Wipro Ltd. (WPRO:IN) (WIT) to Underweight
- JPMorgan Downgrades HCL Technologies (HCLT:IN) to Underweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
